Association study of clusterin polymorphism rs11136000 with late onset Alzheimer's disease in Chinese Han population
- PMID: 22296908
- PMCID: PMC10845609
- DOI: 10.1177/1533317511432735
Association study of clusterin polymorphism rs11136000 with late onset Alzheimer's disease in Chinese Han population
Erratum in
- Am J Alzheimers Dis Other Demen. 2013 Nov;28(7):715
Abstract
Objective: We conducted a case-control study to investigate whether clusterin polymorphism (rs11136000) was associated with late-onset Alzheimer's disease in Chinese Han population.
Methods: Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) assay was performed on genotype rs11136000 and APOEε4 in 127 patients with late-onset Alzheimer's disease and 143 control individuals. Previous published data from other Chinese samples was also included for further meta-analysis.
Results: APOEε4 was demonstrated to increase the risk of Alzheimer's disease in Chinese population (odds ratio = 2.35, 95% confidence interval: 1.40-3.96). There is no significant association between clusterin rs11136000 with late-onset sporadic AD in our small cohort. However, meta-analysis revealed significant allele and genotype differences between Alzheimer's disease and controls following a recessive model.
Conclusion: Clusterin (rs11136000) was associated with Alzheimer's disease in Chinese Han population.
Conflict of interest statement
The authors declared no conflicts of interest with respect to the research, authorship, and/or publication of this article.
Similar articles
-
Clusterin variants are not associated with southern Chinese patients with Alzheimer's disease.Neurobiol Aging. 2014 Nov;35(11):2656.e9-2656.e11. doi: 10.1016/j.neurobiolaging.2014.05.015. Epub 2014 May 29. Neurobiol Aging. 2014. PMID: 24958191
-
The CLU gene rs11136000 variant is significantly associated with Alzheimer's disease in Caucasian and Asian populations.Neuromolecular Med. 2014 Mar;16(1):52-60. doi: 10.1007/s12017-013-8250-1. Epub 2013 Jul 28. Neuromolecular Med. 2014. PMID: 23892938
-
Association between CLU gene rs11136000 polymorphism and Alzheimer's disease: an updated meta-analysis.Neurol Sci. 2018 Apr;39(4):679-689. doi: 10.1007/s10072-018-3259-8. Epub 2018 Feb 2. Neurol Sci. 2018. PMID: 29396813
-
Analyzing 74,248 Samples Confirms the Association Between CLU rs11136000 Polymorphism and Alzheimer's Disease in Caucasian But Not Chinese population.Sci Rep. 2018 Jul 23;8(1):11062. doi: 10.1038/s41598-018-29450-2. Sci Rep. 2018. PMID: 30038359 Free PMC article.
-
Implication of CLU gene polymorphisms in Chinese patients with Alzheimer's disease.Clin Chim Acta. 2010 Oct 9;411(19-20):1516-9. doi: 10.1016/j.cca.2010.06.013. Epub 2010 Jun 22. Clin Chim Acta. 2010. PMID: 20599866
Cited by
-
A Weighted Genetic Risk Score Based on Four APOE-Independent Alzheimer's Disease Risk Loci May Supplement APOE E4 for Better Disease Prediction.J Mol Neurosci. 2019 Nov;69(3):433-443. doi: 10.1007/s12031-019-01372-2. Epub 2019 Jul 25. J Mol Neurosci. 2019. PMID: 31346968
-
Association between clusterin gene polymorphism rs11136000 and late-onset Alzheimer's disease susceptibility: A review and meta-analysis of case-control studies.Exp Ther Med. 2016 Nov;12(5):2915-2927. doi: 10.3892/etm.2016.3734. Epub 2016 Sep 21. Exp Ther Med. 2016. PMID: 27882096 Free PMC article.
-
How understudied populations have contributed to our understanding of Alzheimer's disease genetics.Brain. 2021 May 7;144(4):1067-1081. doi: 10.1093/brain/awab028. Brain. 2021. PMID: 33889936 Free PMC article. Review.
-
Intraventricular infusion of clusterin ameliorated cognition and pathology in Tg6799 model of Alzheimer's disease.BMC Neurosci. 2018 Jan 25;19(1):2. doi: 10.1186/s12868-018-0402-7. BMC Neurosci. 2018. PMID: 29370749 Free PMC article.
-
Roles of constitutively secreted extracellular chaperones in neuronal cell repair and regeneration.Neural Regen Res. 2023 Apr;18(4):769-772. doi: 10.4103/1673-5374.353483. Neural Regen Res. 2023. PMID: 36204835 Free PMC article. Review.
References
-
- Dubois B, Feldman HH, Jacova C, et al. . Research criteria for the diagnosis of Alzheimer’s disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 2007;6(8):734–746. - PubMed
-
- Raber J, Huang Y, Ashford J. ApoE genotype accounts for the vast majority of AD risk and AD pathology. Neurobiol Aging. 2004;25(5):641–650. - PubMed
-
- Lambert JC, Heath S, Even G, et al. . Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer’s disease. Nat Genet. 2009;41(10):1094–1099. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical